Germany – Pharmaceutical products – Arzneimittelverträge mit Beitrittsoption

The subject of this agreement is medicinal products containing the active ingredient atovaquone. | The subject of this agreement is medicinal products containing the active ingredient combination bimatoprost + timolol in an ophthalmic, non-unit-dose dosage form. | The subject of this agreement is medicinal products containing the active ingredient combination bimatoprost + timolol in an ophthalmic, unit-dose dosage form. | The subject of this agreement is medicinal products containing the active ingredient budesonide with the ATC code A07EA06. | The subject of this agreement is medicinal products containing the active ingredient capsaicin in the dosage form of a patch (prescription preparations only). | The subject of this agreement is medicinal products containing the active ingredient chlorthalidone. | The subject of this agreement is medicinal products containing the active ingredient dornase alfa. | The subject of this agreement is medicinal products containing the active ingredient everolimus with the ATC code L04AA18. | The subject of this agreement is medicinal products containing the active ingredient lidocaine in the dosage form of a patch. The subject of this agreement is medicinal products containing the active ingredient loratadine. | The subject of this agreement is medicinal products containing the active ingredient mercaptopurine. | The subject of this agreement is medicinal products containing the active ingredient mesalazine in an oral dosage form. | The subject of this agreement is medicinal products containing the active ingredient mesalazine in the dosage form of rectal foam. | The subject of this agreement is medicinal products containing the active ingredient mesalazine in the dosage form of suppositories. | The subject of this agreement is medicinal products containing the active ingredient olanzapine in the dosage form of dry substance with solvent (TRS). | The subject of this agreement is medicinal products containing the active ingredient...